TrialScientific reports2021

Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection in Taiwan.

Kao-Chi Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.